Non-neuroadapted influenza virus confined to the brain parenchyma does not induce antigenspecific immunity. Nevertheless, infection in this site upregulated major histocompatibility complex (MHC) class I and MHC class II expression and recruited lymphocytes to a perivascular compartment. T cells recovered from the brain had an activated/memory phenotype but did not respond to viral antigens. In contrast, T cells recovered from the brain after infection in a lateral cerebral ventricle, which is immunogenic, showed virus-specific responses. As with infectious virus, influenza virusinfected dendritic cells elicited virus-specific immunity when inoculated into the cerebrospinal fluid but not when inoculated into the brain parenchyma. Thus, inflammation and dendritic cell function were both uncoupled from immune priming in the microenvironment of the brain parenchyma and neither was sufficient to overcome immunological privilege.
Introduction
Invading pathogens typically trigger co-ordinated inflammatory and immune responses. This is achieved through antigen non-specific inflammatory signals stimulating both the afferent and the efferent arms of the immune response and, through immune effector mechanisms, promoting inflammation (Mims, 1982) . In particular, dendritic cells respond to inflammatory stimuli by maturation and migration to lymphoid tissue, where they play a major role in the initiation of antigenspecific immunity (Steinman, 1991 ; Mellman & Steinman, 2001) . Thus, the presence of an inflammatory response to infection generally correlates with specific immunity. The situation may be different in the central nervous system (CNS).
The prolonged survival of allogeneic tissue grafts in the brain implies a degree of immune privilege (Brent, 1990) . The rejection of an intracerebral graft can be triggered by a subsequent extracerebral graft from the same donor, so this privilege probably reflects a lack of immune priming by antigens sequestered in the brain (Medawar, 1948) . Mycobac- terial antigens also appear to be much less inflammatory in the brain parenchyma than in extracerebral sites, probably due to a lack of immune priming (Matyszak & Perry, 1998) . We have previously used a stereotactically guided, small volume inoculation of a non-neuroadapted strain of influenza virus to confine virus infection to the parenchymal substance of the brain and thus to demonstrate that such an infection does not lead to immune priming (Stevenson et al., 1997a) . Infection with the neuroadapted influenza virus A\WSN in the same site also appears not to prime efficiently but, nevertheless, elicits an intracerebral inflammatory response (Stevenson et al., 1997b) . However, because this virus spreads throughout the brain (Stuart-Harris, 1939 ; Takahashi et al., 1995) and reaches the cerebrospinal fluid (CSF) (Stevenson et al., 1997b) , it is unclear whether such inflammation represents the early signs of an immune response consequent upon an extracerebral seeding of infection. Here, we have analysed the local response to infection with a non-neuroadapted influenza virus, which does not produce infectious virions in the brain and thus does not spread. This has allowed us to exclude the possibility of extracerebral infection.
Soluble protein antigens injected into the brain parenchyma can reach the deep cervical lymph nodes and stimulate immune responses (Gordon et al., 1992) . The lack of immune priming by cell-associated antigens such as influenza virus thus suggests that deficient antigen-presenting cell function in the brain is an important factor in immune privilege. 
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Virus-induced intracerebral inflammation Virus-induced intracerebral inflammation Fig. 2 . Prevention of intracerebral inflammation by prior influenza virus neutralization. Influenza virus A/NT/60/68 (H3N2) was incubated with an anti-haemagglutinin H3 MAb (clone BH151) or an anti-haemagglutinin H1 MAb (clone HC132), each as neat infectious allantoic fluid with 10 % monoclonal ascites on ice for 1 h prior to intracerebral inoculation. For clone BH151, this was a threefold excess of the dose required to achieve 90 % inhibition of haemagglutination by the same quantity of virus. Clone HC132 inhibited haemagglutination by influenza virus A/PR/8/34 (H1N1) but had no effect on influenza virus A/NT/60/68 (data not shown). (A)-(E) Anti-MHC class I staining ; (F-J) anti-MHC class II staining. The arrow in (F) indicates normal MHC class II expression in the choroid plexus. All brains are shown 10 days after the intracerebral inoculations indicated. Consistent results were obtained with at least three individual mice in each experimental group.
While the brain parenchyma lack classical dendritic cells (Hart & Fabre, 1981) , the bone marrow-derived perivascular microglial cells (Hickey & Kimura, 1988) resemble immature antigenpresenting cells (Carson et al., 1998) and can be induced to differentiate towards a dendritic cell phenotype in vitro (Aloisi et al., 1999 ; Santambrogio et al., 2001) . CD11c + microglia (Fischer et al., 2000 ; Serafini et al., 2000) also share some features with dendritic cells and can prime naive T cells in vitro (Fischer & Reichmann, 2001) . However, there is clearly a functional deficit in vivo, which presumably applies both to the carriage of cell-associated antigens from the brain parenchyma to lymph nodes and to the priming of intracerebral T cells in situ. Either should suffice to overcome immune privilege.
Two possibilities, not mutually exclusive, are that bone marrow-derived microglia are not functionally equivalent to dendritic cells in vivo and that the microenvironment of the brain parenchyma does not support immune priming by any cell type. Influenza virus-infected dendritic cells are known to stimulate potent immune responses in vitro (Macatonia et al., 1989 ; Nonacs et al., 1992) and in vivo (Hamilton-Easton & Eichelberger, 1995 ; Lopez et al., 2000) . Thus, we have used ex vivo dendritic cells infected with influenza virus to explore the possibility that professional antigen-presenting cells delivered to the brain parenchyma might overcome the barrier to immune priming.
Methods
Mice and viruses. C57BL\10 mice were obtained from Harlan, housed under UK Home Office-approved conditions and used at 8-10 weeks of age. Influenza virus A\NT\60\68 was grown and titrated by standard methods (Stevenson et al., 1997a) . The infectious allantoic fluid used for all intracerebral inoculations contained 1i10% haemagglutination units (HAU)\ml, 1i10) p.f.u.\ml and 1i10"! electron microscopic virus particles\ml. Influenza virus (5 HAU) was administered under brief general anaesthesia as either 0n5 µl in the lateral cerebral ventricle or anterior caudoputamen or 30 µl intranasally. All intracerebral injections were performed under stereotactic guidance, as described previously (Stevenson et al., 1997a) . To harvest cells, anaesthetized mice were exsanguinated by trans-cardiac perfusion with 30 ml heparinized PBS. Spleens and lymph nodes were disrupted into single-cell suspensions and used directly. Lymphocytes in brain or lung homogenates were recovered by centrifugation (1000 g for 15 min) on 60\40 % Percoll gradients (Hawke et al., 1998) .
Preparation of dendritic cells. Dendritic cells were purified from mouse spleens by standard methods (Austyn et al., 1983 ; KupiecWeglinski et al., 1988) . Briefly, low-density cells were enriched from splenocytes by centrifugation onto a cushion of dense (1n08 g\ml) BSA. These cells were adhered to plastic for 3 h at 37 mC. Non-adherent cells were removed by pipetting and discarded. After overnight culture at 37 mC, cells were detached by pipetting and readhered to plastic for 2 h to remove macrophages. The proportion of dendritic cells [major histocompatibility complex (MHC) class II + , B220 − , Mac-1 − , CD3 − and Fc receptor − ] in the final non-adherent cell population was 50-70 %. Table 1 . Functional analysis of T cells recovered from infected organ homogenates 10 days after inoculation of 5 HAU influenza virus A/NT/60/68 by the route indicated Cells were recovered by Percoll density gradient centrifugation from homogenates of brain (after ventricular or parenchymal infections) or lung (after intranasal infection). Total cell numbers isolated per infected organ are the meanpSEM of results from 8 to 10 pairs of mice for each route of immunization, pooled from three separate experiments. Peripheral blood from pairs of naive mice (n l 6) analysed at the same time contained 26n8p3n0 % CD4 + T cells and 15n5p1n9 % CD8 + T cells, with a CD4 : CD8 ratio of 1n8p0n1. Although a greater proportion of the intracerebral T cells were CD4 + after ventricular virus inoculation, this was not statistically significant (P l 0n13 by paired t-test, comparing the CD4 : CD8 ratios of the intracerebral cells isolated after ventricular virus infection with those in peripheral blood). Cytotoxicity before restimulation was tested in parallel with proliferation using cells pooled from the same mice for each assay. At the same time, cells were restimulated in vitro for 5 days with virus-infected feeder cells before testing cytotoxicity again. Proliferation index l mean response to influenza-infected targets (c.p. 
Route of infection

Ventricular
Parenchymal Intranasal These cells were infected for 2 h with influenza virus A\NT\60\68 (2 p.f.u. per cell) and washed three times prior to intracerebral microinjection, as described above. Cell-free virus was undetectable by plaque assay in the intracerebral inoculum.
ELISA. Influenza virions were purified from infectious allantoic fluid by sucrose density gradient centrifugation, washed in PBS, lysed with detergent and adsorbed overnight onto Nunc Polysorb immunoplates (Life Technologies). Virus-specific IgG, IgA and IgM were assayed as described previously (Stevenson et al., 1997a) .
Restimulation and assay of CD8 M cytotoxic T lymphocytes (CTL).
Single-cell suspensions from lymph nodes (5i10& cells\ml) or cells from infected brains (5i10% cells\ml) were restimulated with virusinfected feeder cells (1i10' cells\ml) in 2 ml cultures. Spleen cells (1i10' cells\ml) were restimulated with virus-infected feeder cells (3i10& cells\ml) in 15 ml cultures. Syngeneic feeder spleen cells were incubated with 400 µl influenza virus A\NT\60\68-infected allantoic fluid per 1i10( cells at 37 mC for 1 h, irradiated (20 Gy) and washed twice in complete medium before use. Cytotoxicity was tested after 5 days of culture in complete medium at 37 mC with 5 % CO # . &"Cr-labelled EL-4 cells (100 µCi\1i10' cells) were either incubated with complete medium alone, pulsed with an H-2D b -restricted influenza virus nucleoprotein epitope ( 1 µM ASNENMDAM) or infected with influenza virus A\NT\60\68 (5 p.f.u. per cell). After 1 h at 37 mC, the target cells were washed twice in complete medium and incubated with CTL for 4 h before harvesting supernatants for scintillation counting. Chromium release from the targets alone was 5-15 % of the release with Triton.
Proliferation assay. Lymphocytes were aliquotted into triplicate cultures (2i10$ cells per well) in Terasaki plates (20 µl per well) or 96-well plates (2i10& cells per well) with irradiated (20 Gy) naive feeder spleen cells (2i10% or 2i10& per well, respectively). Feeder cells were either untreated or infected with influenza virus, as for CTL restimulation.
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After culture for 72 h at 37 mC with 5 % CO # using complete medium but with 1 % normal mouse serum substituted for 10 % foetal calf serum, 0n1-1n0 µCi [$H]thymidine was added to each well and the cells were harvested for scintillation counting 18 h later.
Flow cytometry. Lymphocytes were incubated for 15 min on ice with 5 % normal mouse serum and 5 % normal rat serum followed by a 30 min incubation with rat anti-mouse antibodies as follows : anti-CD4, KT6-phycoerythrin (Serotec) ; anti-CD8, KT15-FITC (Serotec) ; anti-CD62L, biotinylated MEL-14 ; anti-CD44, biotinylated IM7.8.1 ; antiCD49d, biotinylated PS\2 ; or anti-CD25, Quantum Red-3C7 (Sigma). After washing in PBS\FCS (1 %), streptavidin-Quantum Red (Sigma) was added for 15 min followed by a further wash. Samples were analysed on a FACSort instrument using , version 1.1 (Becton-Dickinson).
Immunohistochemistry. Acetone-fixed frozen sections (7-10 µm) were preincubated in 10 % rabbit serum, and stained with the following rat anti-mouse antibodies : anti-CD8, YTS169.4 ; anti-CD4, GK1.5 ; anti-MHC class I, M1-42.3.9.8 ; anti-MHC class II, M5\114.15.2 ; and anti-B220, RA3-6B2 (Serotec). A mouse-absorbed, biotinylated, rabbit anti-rat serum (Dako) was used as the secondary antibody, followed by streptavidin-biotin-peroxidase complexes (Vector Laboratories). For anti-virus staining, the sections were preincubated in 10 % goat serum and then incubated with an anti-influenza virus ribonucleoprotein rabbit serum (Reinacher et al., 1983) followed by a peroxidasecoupled goat anti-rabbit serum (Vector Laboratories). All antibody incubations were for 1 h at room temperature and sections were washed three times in PBS after each incubation. Endogenous peroxidase activity was blocked with 0n3 % hydrogen peroxide in methanol after the primary antibody incubation. Diaminobenzidine was used as the peroxidase substrate and haematoxylin was used as the counterstain.
Results
Inflammation after virus inoculation into different intracerebral sites
Influenza virus A\NT\60\68 (5 HAU) was inoculated into either a lateral cerebral ventricle, the anterior caudoputamen, or the lung. We have previously demonstrated that small volume ( 1 µl) inoculation of influenza virus into the anterior caudoputamen (parenchymal substance of the brain) does not induce detectable immune priming (Stevenson et al., 1997a) . Here, we looked at the local consequences of equivalent infections. Surprisingly, mice given virus into either the CSF (Fig. 1A-F) or the brain parenchyma (Fig. 1G-L) all showed a marked upregulation of intracerebral MHC antigen expression (Fig. 1A, B and G-H) together with a local infiltration of T and B cells (Fig. 1C-E and I-J) . The lymphocytic infiltrates were predominantly perivascular. After intraventricular virus inoculation, periventricular infiltrates were also prominent, particularly for the CD4 + T cell subset. In all brains, the extent of observed MHC class I and II upregulation extended considerably beyond the extent of infection, although with parenchymal infection, the choroid plexus and contralateral hemisphere appeared normal (Fig. 1G-H) .
No bacterial or fungal growth was apparent after incubation of the influenza virus A\NT\60\68 (H3N2)-infected allantoic fluid at 37 mC in standard tissue culture or bacteriological media. To establish that the intracerebral inflammation was due to infection with influenza virus rather than a contaminating virus, infectious allantoic fluid was treated with an antiinfluenza virus haemagglutinin monoclonal antibody (MAb) before intracerebral inoculation. Prior anti-haemagglutinin H3 neutralization but not incubation with a control anti-haemagglutinin H1 MAb entirely prevented the upregulation of MHC class I and class II expression (Fig. 2) and any lymphocytic infiltration (data not shown) associated with intracerebral A\NT\60\68 injection. Uninfected allantoic fluid also caused no significant intracerebral inflammation (Fig. 2) . Thus, the upregulation of MHC expression and recruitment of lymphocytes depended on the presence of infectious influenza virus.
Influenza virus is generally a lytic virus. This probably explains the destruction of ependymal cells lining the cerebral ventricles (Fig. 1F ) and the loss of cells from around the site of parenchymal infection (Fig. 1L, compare with Fig. 2) . The crucial deficit in neuronal infection is a lack of haemagglutinin processing, such that any virions produced cannot enter new cells (Schlesinger, 1950) . Plaque assays and egg infection assays from days 1-7 after infection failed to recover infectious virus from inoculated brains (limit of detection 10 infectious units per brain). Viral antigen, detectable by immunostaining, and viral mRNA, detectable by RT-PCR, persisted for approximately 2 weeks after ventricular infection and approximately 1 month after parenchymal infection (data not shown). The extent of histological inflammation declined with the decline in surviving viral antigen.
Analysis of infiltrating lymphocytes
After parenchymal virus infection, the presence of infiltrating lymphocytes in the absence of detectable anti-viral serum antibody suggested that these cells had been recruited without an antigen-specific immune response and, thus, that they were not virus-specific. To test this possibility, T cells were recovered from infected brains 10 days after ventricular or parenchymal influenza virus infection or from infected lungs 10 days after intranasal virus inoculation and were assayed for virus specificity in vitro (Table 1 ). The cells recovered after ventricular or intranasal, but not after parenchymal, virus infections showed virus-specific proliferation and cytotoxicity.
Virus-specific CTL precursors could be recovered from the brain, spleen and deep cervical lymph nodes after ventricular or intranasal infections but not after parenchymal infection (Table  1 ). All mice given intracerebral virus were checked for the presence of virus-specific serum antibody. As observed previously (Stevenson et al., 1997a) , virus-specific antibody was undetectable in the serum or the CSF after parenchymal virus inoculation (Fig. 3) . Thus, there was no evidence of an antigen-specific immune response to parenchymal influenza virus infection, either systemically or locally, within the CNS.
Flow cytometric phenotype of infiltrating lymphocytes
Despite their differences in specificity, the infiltrating T cells recovered after parenchymal or ventricular virus infections showed little difference in surface phenotype (Fig. 4) . In each case, the predominant pattern observed was CD44 hi \ CD62L lo \CD49d hi , implying a memory or activated state. There was little or no evidence of naive (CD44 lo \ CD62L hi \CD49d lo ) T cells entering the brain in response to influenza virus infection. The T cells recovered after ventricular BHEA Virus-induced intracerebral inflammation Virus-induced intracerebral inflammation Cr-release assay with either unpulsed (#) or ASNENMDAM peptide-pulsed ($) target cells. Lymphocytes for restimulation were pooled from three individual mice and either recovered from brain homogenates by centrifugation on discontinuous Percoll density gradients or taken directly from single-cell spleen homogenates, as indicated. In infection did have a higher proportion of CD25 + (23 %) and CD62L lo (87 %) cells than those recovered after parenchymal virus infection (13 and 76 %, respectively), suggesting a greater degree of acute activation. This was perhaps consistent with an ongoing immune response only after influenza virus inoculation into the CSF. The T cells recovered from virusinfected lungs were mostly of the CD8 + subset but were otherwise similar to those from infected brains in having an activated\memory phenotype. Because the lung receives a dual blood supply from the bronchial and pulmonary arteries, complete perfusion of this organ was difficult to achieve and the small numbers of CD44 lo and CD49d lo T cells isolated were probably intravascular contaminants. In no experiment were significant numbers of naive phenotype T cells isolated from influenza virus-infected brains. T cells recovered from uninfected brains were also uniformly CD44 hi CD49d hi (data not shown).
Dendritic cell inoculations
The fact that local inflammation and lymphocyte recruitment occurred in the absence of immune priming implied that these events were insufficient to overcome immune privilege. This raised the question as to what other features of the brain parenchyma were maintaining immune privilege. Since classical dendritic cells are conspicuously lacking from the brain parenchyma, we next addressed the possible contribution of a lack of suitable antigen-presenting cells. Thus, we introduced influenza virus-infected dendritic cells into this site to try to generate an immune response. Dendritic cells were purified as low-density, partially adherent cells from naive mouse spleens and infected in vitro with influenza virus just prior to inoculation. Initial experiments confirmed that such a population was capable of immune priming after subcutaneous footpad injection. Virus-specific T cells were present in lymphoid tissue (Fig. 5A, B ) and virus-specific antibody was present in serum (data not shown).
Influenza virus-infected dendritic cells were then introduced by small volume sterotactic injection into the lateral cerebral ventricle or the brain parenchyma. Virus-specific serum IgG titres indicated systemic immune priming after injection into a lateral cerebral ventricle (Fig. 5C ). This was in accordance with a previous report that intrathecally injected dendritic cells can cause some lymphocyte infiltration into the CNS (Carson et al., 1999) . However, dendritic cells injected into the anterior caudoputamen elicited no detectable serum antibody response (Fig. 5C ). Virus-specific antibody was also undetectable in the CSF after parenchymal dendritic cell injection (data not shown). Finally, virus-specific CD8 + T cell precursors could be recovered from the brain and spleen after dendritic cell injection into the CSF but from neither site after dendritic cell injection each case, lymphocyte viability was checked by Trypan blue exclusion just prior to assay. One of three equivalent experiments is shown. P. G. Stevenson, J. M. Austyn and S. Hawke P. G. Stevenson, J. M. Austyn and S. Hawke into the brain parenchyma (Fig. 5D) . Thus, the presence of antigen-presenting cells in the brain parenchyma was not sufficient to overcome the barrier to immune priming.
Discussion
Influenza virus infection confined to the brain parenchyma elicited no detectable immune response but, nevertheless, caused a massive upregulation of intracerebral MHC antigen expression together with local lymphocyte recruitment. T cells recovered from the brain after parenchymal infection, unlike control populations, showed no recognition of influenza virus antigens ex vivo. Thus, the local inflammatory response was uncoupled from immune priming. We hypothesized that the infiltrating cells were not primed because of a lack of appropriate intracerebral antigen-presenting cells. However, influenza virus-infected dendritic cells, which were immunogenic when inoculated into the footpad or the CSF, did not prime virus-specific immune responses from the brain parenchyma. We conclude that, while the brain can provide inflammatory signals to attract primed lymphocytes, there is a specific microenvironmental deficit that prevents initial priming. The brain has historically been viewed as a site of decreased immune reactivity and inflammation. However, there is still controversy over the factors involved ; for example, whether a lack of immune priming or a defect in intracerebral T cell function is the crucial influence (Streilein, 1993) . We have investigated immune privilege using intracerebral challenge with viral antigens, since immune evolution has probably been driven by the requirement to detect and eliminate such parasites. While intracerebral autoimmunity may be downregulated by lymphocyte apoptosis (Ford et al., 1996 ; Gold et al., 1997) , this does not seem to be a major feature of influenza virus infection. Indeed viable, activated, virus-specific CD8 + T cells can persist long-term in the CNS (Hawke et al., 1998) . Brain gangliosides have been reported to inhibit T cell proliferation (Irani et al., 1996) but again we have found no evidence for this during influenza virus infection : virus-specific intracerebral T cells proliferate in vivo (Stevenson et al., 1997c) and in vitro (Stevenson et al., 1997a ; Hawke et al., 1998) . Overall, anti-viral T cells appear to function very effectively in the brain. Here, intracerebral virus infection recruited primed T cells even when they were not virus-specific (Table 1, Fig. 4) . The focus in understanding CNS immune privilege is thus shifted onto the generation of primed T cells and onto the antigen-presenting cell.
Cells with a dendritic cell-like surface phenotype accumulate in the brain during chronic toxoplasma infection (Fischer et al., 2000) and experimental allergic encephalomyelitis (Serafini et al., 2000) . The precise function of these cells in vivo remains unclear. Even though influenza virus infection stimulated a local inflammatory response in the brain parenchyma (Fig. 1) , it did not stimulate any resident dendritic cell-like antigenpresenting cells to generate detectable immunity. And, while influenza virus-infected dendritic cells are normally highly efficient at presenting viral antigens in vivo, these were ineffective when inoculated into the brain parenchyma (Fig. 5) . This suggested that it is not the lack of dendritic cells but an inappropriate environment for their function that prevents immune priming. It may be that the brain microenvironment fails to support normal dendritic cell migration. A lack of suitable anatomical pathways, chemokines or adhesion molecules could all contribute. The end result is that inflammation can be driven locally but that priming requires extracerebral antigen.
What are the potential implications of the uncoupling of inflammation and immunity in the brain parenchyma? Congenital infections and the retrograde transport of virions along peripheral neurons are both mechanisms by which a virus may reach the brain while avoiding extracerebral immune priming. Viruses may also express genes uniquely in the brain during a period of latency in this site. A lack of immune priming could then contribute to the persistence of an intracerebral, inflammatory focus. The immune response to unrelated extracerebral infections could have significant effects on antigen non-specific intracerebral inflammation by increasing the circulating pool of activated cells capable of entering the brain. Clearly, a priority with any intracerebral inflammatory disease is to consider not only antigen-specific immunity but also the potential role of non-antigen-specific responses to cryptic infections.
